Skip to content

Clinical trials

Phase 3 Lymphoma, Non-Hodgkin trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Non-Hodgkin Phase: Phase 3 Country / region: China Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20102
20111
20121
20132
20151
20161
20171
20182
20192
20201
20214
20223
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting11
Completed9
Recruiting2
Terminated2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Loxo Oncology, Inc.5
Genmab3
Acerta Pharma BV2
Bayer2
Hoffmann-La Roche2
Novartis Pharmaceuticals2
BeOne Medicines1
Celgene1
Denovo Biopharma LLC1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Non-Hodgkin26
Lymphoma, B-Cell8
Lymphoma6
Hematologic Diseases5
Lymphoma, Large B-Cell, Diffuse5
Leukemia, Lymphocytic, Chronic, B-Cell4
Neoplasms4
Lymphoma, Mantle-Cell3
Lymphoma, Follicular2
Leukemia, B-Cell1

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.